Reta glucagon-like peptide-1 (GLP-1) receptor agonists provide a groundbreaking strategy to diabetes management. These innovative medications operate by mimicking the physiological actions of GLP-1, a hormone released https://peakbookmarks.com/story20858923/glp-1-receptor-agonists-as-a-novel-therapy-for-diabetes